You are currently viewing the editor's summary.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Chemo hitches a ride
Anticancer agents such as chemotherapy are widely used; however, their efficacy and safety are hampered by off-target effects in surrounding healthy cells and tissues. To improve anticancer drug delivery, De La Fuente et al. identified four RNA aptamers that specifically recognized mouse and human myeloid cells infiltrating head and neck squamous cell carcinoma (HNSCC). Conjugating chemotherapeutic agent doxorubicin to these aptamers allowed drug delivery to the local tumor microenvironment in mouse models of breast cancer and fibrosarcoma via tumor-infiltrating myeloid cells and increased survival over the unmodified drug. This preclinical study suggests that RNA aptamers are a candidate approach to target drugs to tumors in humans.
- Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
This is an article distributed under the terms of the Science Journals Default License.
